Prelude Capital Management’s Iovance Biotherapeutics IOVA Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q1	–	Sell	-12,000	Closed	-$97.6K	–	1440
2023 Q4	$97.6K	Buy	+12,000	New	+$62.8K	0.01%	1030
2023 Q2	–	Sell	-46,435	Closed	-$284K	–	1248
2023 Q1	$284K	Buy	+46,435	New	+$320K	0.02%	668
2021 Q1	–	Sell	-4,481	Closed	-$208K	–	1760
2020 Q4	$208K	Sell	4,481 -5,325	-54%	-$211K	0.02%	1097
2020 Q3	$323K	Sell	9,806 -1,852	-16%	-$56.8K	0.05%	536
2020 Q2	$320K	Buy	11,658 +3,559	+44%	+$117K	0.05%	602
2020 Q1	$242K	Sell	8,099 -6,669	-45%	-$177K	0.05%	414
2019 Q4	$409K	Buy	14,768 +75	+0.5%	+$1.71K	0.05%	612
2019 Q3	$267K	Buy	14,693 +14,633	+24,388%	+$324K	0.03%	684
2019 Q2	$1K	Buy	+60	New	+$904	﹤0.01%	1593
2018 Q4	–	Sell	-5,500	Closed	-$62K	–	2003
2018 Q3	$62K	Sell	5,500 -2,500	-31%	-$35.5K	﹤0.01%	1076
2018 Q2	$102K	Sell	8,000 -2,500	-24%	-$36.5K	0.01%	909
2018 Q1	$177K	Buy	10,500 +500	+5%	+$7.57K	0.02%	708
2017 Q4	$80K	Buy	10,000 +2,500	+33%	+$20.1K	0.01%	843
2017 Q3	$58K	Sell	7,500 -32,034	-81%	-$203K	0.01%	1055
2017 Q2	$291K	Sell	39,534 -300	-0.8%	-$1.91K	0.03%	466
2017 Q1	$297K	Buy	39,834 +15,116	+61%	+$111K	0.04%	439
2016 Q4	$172K	Buy	24,718 +4,773	+24%	+$32.8K	0.02%	638
2016 Q3	$164K	Buy	19,945 +18,945	+1,895%	+$160K	0.02%	629
2016 Q2	$8K	Sell	1,000 -15,500	-94%	-$97.3K	﹤0.01%	1410
2016 Q1	$84K	Buy	+16,500	New	+$90.3K	0.01%	815
2015 Q3	–	Sell	-3,700	Closed	-$34K	–	1638
2015 Q2	$34K	Buy	3,700 +2,500	+208%	+$27.9K	0.01%	1244
2015 Q1	$15K	Buy	+1,200	New	+$13.5K	﹤0.01%	1789